Description Usage Arguments Details Value Author(s) References Examples
Gamma Poisson Shrinkage model proposed by DuMouchel (1999) extended to the multiple comparison framework.
1 2 3 4 |
DATABASE |
Object returned by the function |
RR0 |
Value of the tested risk. By default, |
MIN.n11 |
Minimum number of notifications for a couple to be potentially considered as a signal. This option does not affect the calculation of the hyper parameters. By default, |
DECISION |
Decision rule for the signal generation based on 1 = FDR (Default value) 2 = Number of signals 3 = Ranking statistic. See |
DECISION.THRES |
Threshold for |
RANKSTAT |
Statistic used for ranking the couples: 1 = Posterior probability of the null hypothesis 2 = 5% quantile of the posterior distribution of lambda 3 = Posterior Expectation of log(lambda,2) |
TRONC |
If TRUE, only the data with at least |
TRONC.THRES |
See |
PRIOR.INIT |
Vector of initialization of the prior parameters (alpha1, beta1, alpha2, beta2, w). By default, |
PRIOR.PARAM |
Chosen hyper parameters. By default, |
Each observed count n11 is assumed to be drawn from a Poisson distribution with parameters
e11 where e11 is the expected count under the hypothesis of independence between the adverse events and the drugs (n1. * n.1 / N, see as.PhViD
). lambda is a priori assumed to be distributed according to a mixture of two gamma distributions: lambda ~ w Ga(alpha1,beta1) + (1-w) Ga(alpha2,beta2).
ALLSIGNALS |
Data.frame summarizing the results of all couples with at least |
SIGNALS |
Same Data.frame as |
NB.SIGNALS |
Number of generated signals. |
INPUT.PARAM |
Parameters entered in the function. |
PARAM |
A list that contains the prior hyper parameters ( |
Ismaïl Ahmed & Antoine Poncet
Ahmed I, Haramburu F, Fourrier-Réglat A, Thiessard F, Kreft-Jais C, Miremont-Salamé G, Bégaud B, Tubert-Bitter P. Bayesian pharmacovigilance signal detection methods revisited in a multiple comparison setting. Stat Med. 2009 Jun 15;28(13):1774-1792.
DuMouchel W, Bayesian Data Mining in Large Frequency Tables, with an Application to the FDA Spontaneous Reporting System, The American Statistician, 1999, 53, 177-190.
Szarfman A, Machado S, O'Neill R, Use of Screening Algorithms and Computer Systems to Efficiently Signal Higher-Than-Expected Combinations of Drugs and Events in the US FDA's Spontaneous Reports Database Drug Safety, 2002, 25, 381-392.
1 2 3 4 5 6 7 8 9 10 11 | ## start
#data(PhViDdata.frame)
#PhViDdata <- as.PhViD(PhViDdata.frame)
#res <- GPS(PhViDdata)
#List of signals generated by the decision rule proposed
#by Szarfman et al. (2002)
#res2 <- GPS(PhViDdata, DECISION = 3, DECISION.THRES = 2, RANKSTAT = 2)
## end
|
Loading required package: LBE
Loading required package: MCMCpack
Loading required package: coda
Loading required package: MASS
##
## Markov Chain Monte Carlo Package (MCMCpack)
## Copyright (C) 2003-2020 Andrew D. Martin, Kevin M. Quinn, and Jong Hee Park
##
## Support provided by the U.S. National Science Foundation
## (Grants SES-0350646 and SES-0350613)
##
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.